Reduced CCR4, interleukin-13 and GATA-3 up-regulation in response to type 2 cytokines of cord blood T lymphocytes in infants at genetic risk of type 1 diabetes

Immunology

Volumn 121, Issue 2, 2007, Pages 189-196

  Luopajärvi, Kristiina ^a   Skarsvik, Susanne ^b   Ilonen, Jorma ^c,d   Åkerblom, Hans K ^a   Vaarala, Outi ^b,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

CCR4; T lymphocytes; Type 1 diabetes

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYTOKINE; CYTOKINE RECEPTOR; HLA DQ2 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; PHYTOHEMAGGLUTININ; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; AUTOIMMUNITY; BIRTH; BLOOD ANALYSIS; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; POLARIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UMBILICAL CORD BLOOD; UPREGULATION;

CELL POLARITY; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; FETAL BLOOD; GATA3 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; INFANT, NEWBORN; INTERLEUKIN-13; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; UP-REGULATION;

EID: 34247510068     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02557.x     Document Type: Article

References (27)

1. Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi F, Marino V, Scola L, Caruso C. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity. Hum Immunol 2001 62 : 705 13.
2. Llewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, Cohen J, Altmann DM. HLA class II polymorphisms determine responses to bacterial superantigens. J Immunol 2004 172 : 1719 26.
3. Petrovsky N, Harrison LC. HLA class II-associated polymorphism of interferon-gamma production. Hum Immunol 1997 53 : 12 6.
4. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998 19 : 568 74.
5. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997 185 : 825 31.
6. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003 21 : 713 58.
7. Bonecchi R, Bianchi G, Bordignon Panina P et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998 187 : 129 34.
8. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998 338 : 436 45.
9. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000 18 : 217 42.
10. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000 100 : 655 69.
11. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997 89 : 587 96.
12. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997 272 : 21597 603.
13. Sjöroos M, Itiä A, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 1995 18 : 870 7.
14. Laaksonen M, Pastinen T, Sjöroos M et al. HLA class II associated risk and protection against multiple sclerosis - a Finnish family study. J Neuroimmunol 2002 122 : 140 5.
15. Skarsvik S, Puranen J, Honkanen J, Roivainen M, Ilonen J, Holmberg H, Ludvigsson J, Vaarala O. Decreased in vitro type 1 immune response against coxackie virus B4 in children with type 1 diabetes. Diabetes 2006 55 : 996 1003.
16. Skarsvik S, Ludvigsson J, Vaarala O. Aberrant regulation of interleukin-12 receptor beta-2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes. Immunology 2005 114 : 287 93.
17. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998 9 : 745 55.
18. Kishikawa H, Sun J, Choi A, Miaw S, Ho I. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol 2001 167 : 4414 20.
19. Kitamura N, Kaminuma O, Mori A, Hashimoto T, Kitamura F, Miyagishi M, Taira K, Miyatake S. Correlation between mRNA expression of Th1/Th2 cytokines and their specific transcription factors in human helper T-cell clones. Immunol Cell Biol 2005 83 : 536 41.
20. Nepom GT, Seyfried CE, Holbeck SL, Wilske KR, Nepom BS. Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis. Lancet 1986 2 : 1002 5.
21. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002 2 : 647 55.
22. Giordano C, De Maria R, Mattina A et al. Analysis of T-lymphocyte subsets after phytohemagglutinin stimulation in normal and type 1 diabetic mothers and their infants. Am J Reprod Immunol 1992 28 : 65 70.
23. Brown MA, Rad PY, Halonen MJ. Method of birth alters interferon-gamma and IL-12 production by cord blood mononuclear cells. Pediatr Allergy Immunol 2003 14 : 106 11.
24. Lohmann T, Laue S, Nietzschmann U, Kapellen TM, Lehmann I, Schroeder S, Paschke R, Kiess W. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 2002 51 : 2474 80.
25. Halminen M, Simell O, Knip M, Ilonen J. Cytokine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated autoantibodies. Scand J Immunol 2001 53 : 510 3.
26. Kretowski A, Mysliwiec J, Kinalska I. In vitro interleukin-13 production by peripheral blood in patients with newly diagnosed insulin-dependent diabetes mellitus and their first degree relatives. Scand J Immunol 2000 51 : 321 5.
27. Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invst 2002 109 : 131 40.